Select Page
The Oslo Medicines Initiative: a new social contract with pharma
EPHA #A2MDialogues
REGISTER HERE

15 June 2021

13:00-14:00 CEST

online

Continuing our successful online discussions on key access to medicines (A2M) priorities bringing together thought leaders and policy-makers, academics, industry representatives and NGOs, for a frank discussion of European pharmaceutical policies.

Take part in our #A2MDialogues to share your questions and ideas and help us develop actionable #A2Msolutions for decision-makers in Europe. 

The Oslo Medicines Initiative: Better access to effective, novel, high-priced medicines – a new vision for collaboration between the public and private sectors is a new initiative of the WHO Regional Office for Europe, developed together with the Norwegian Ministry of Health and Care Services and the Norwegian Medicines Agency.

The Initiative aims to provide a neutral platform for the public and private sectors to jointly outline a vision for equitable and sustainable access to effective, innovative and affordable medicines.

Join us to discuss why a new social contract is needed to build an environment of mutual trust and cooperation between the pharmaceutical industry, governments and patients.

 

 

#A2MDialogues

Panelists

Dr Natasha Azzopardi-Muscat

Director of the Division of Country Health Policies and Systems

WHO European Region

Dr Audun Haga

Director General

Norwegian Medicines Agency

 

 

Moderator

Yannis Natsis

Policy Manager, Universal Access and Affordable Medicines

European Public Health Alliance

Catch up on EPHA’s other #A2MDialogues below

Negotiating with pharma: lessons from the EU COVID-19 vaccine negotiations

12:00-13:00 CEST | 18 May 2021 

Sustainable access to effective antibiotics - what should the EU do?

15 April 2021

After COVID-19, what's next for EU medicines policies?

9 March 2021

Getting it right: Recommendations for a European BARDA

8 December 2020

The Presidencies’ perspective on the pharmaceutical strategy: Europe’s to-do list on access to medicines

25 November 2020

Pharma & COVID19: Winners, losers, prospects

19 November  2020

The EU's IP strategy: Enabler or barrier?

27 October 2020

Unleashing meaningful innovation through regulatory reform

19 October 2020

Follow on social media

#A2MDialogues

#A2Msolutions

Contact

Yannis Natsis

Policy Manager, Universal Access and Affordable Medicines, EPHA
yannis@epha.org